← All Conduit Pharmaceuticals INC filings

Conduit Pharmaceuticals INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
CDT
Conduit Pharmaceuticals INC
10-K: CDT Equity Inc. Details Securities and Corporate Structure
CDT Equity Inc. files its annual report detailing its securities, corporate governance, financial metrics, and future outlook, highlighting ongoing development and strategic partnerships.
NASDAQ
CDT
Conduit Pharmaceuticals INC
10-K: Conduit Pharmaceuticals Reports on Securities and Corporate Governance in Annual 10-K Filing
Conduit Pharmaceuticals details its securities, governance structure, and risk factors in its annual 10-K filing, highlighting its focus on clinical asset development and AI integration.
NASDAQ
CDT
Conduit Pharmaceuticals INC
10-K: Conduit Pharmaceuticals Details Securities in 10-K Filing
Conduit Pharmaceuticals outlines its capital structure, including common and preferred stock, and various warrants in its latest 10-K filing.